VKH
LUMO

Virtu KCG Holdings’s Lumos Pharma, Inc. Common Stock LUMO Stock Holding History

Virtu KCG Holdings’s Portfolio LUMO Stock Details LUMO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q2 		$77K Buy
+1,159
New +$143K ﹤0.01% 2485
2017
Q1 		– Sell
-3,481
Closed -$322K – 3855
2016
Q4 		$322K Buy
+3,481
New +$392K 0.01% 2006

Other funds holding LUMO

First Eagle Investment Management
First Eagle Investment Management New York $59B AUM 32.99% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
GPP
Great Point Partners Greenwich, Connecticut $435M AUM 318.81% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
CCI
Columbus Circle Investors $2.28B AUM 135.57% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
BIM
Bogle Investment Management Newton Lower Falls, Massachusetts $63M AUM 51.97% 1-Year Est. Return

Virtu KCG Holdings's LUMO Position: Q2 2017 in Review

Virtu KCG Holdings opened a new position in Lumos Pharma, Inc. Common Stock (LUMO) in Q2 2017: 1,159 shares worth $77K. The stake represents ﹤0.01% of the portfolio and ranks #2485 among its holdings. This is a return to the name: Virtu KCG Holdings previously reported a position in LUMO as recently as Q4 2016.

Virtu KCG Holdings first reported a position in LUMO in Q4 2016 and has held it in 2 quarters since. The position peaked at $322K in Q4 2016. 110 funds tracked by Wall St. Rank hold LUMO as of Q2 2017.

  • Virtu KCG Holdings held 1,159 shares of Lumos Pharma, Inc. Common Stock worth $77K as of Q2 2017.
  • Lumos Pharma, Inc. Common Stock was a new Virtu KCG Holdings position in Q2 2017.
  • Lumos Pharma, Inc. Common Stock made up ﹤0.01% of Virtu KCG Holdings's portfolio in Q2 2017, its #2485 holding.
  • Virtu KCG Holdings first reported a position in Lumos Pharma, Inc. Common Stock in Q4 2016 and has held it in 2 quarters since.
  • Virtu KCG Holdings's Lumos Pharma, Inc. Common Stock position peaked at $322K in Q4 2016.
  • 110 funds tracked by Wall St. Rank held Lumos Pharma, Inc. Common Stock as of Q2 2017.

Based on Virtu KCG Holdings's 13F filing for Q2 2017, filed 11 Aug 2017.